Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-hydroxymethyl-3-hydroxy-6-(1-hydroxy-2-tert-butylamino Ethyl)pyridine, Dihydrochloride
2. Cp 24315-1
3. Cp-24,314-1
4. Cp-24315-1
5. Maxair
6. Pirbuterol
7. Pirbuterol Acetate Salt
8. Pirbuterol Dihydrochloride
9. Pirbuterol Sulfate
10. Pyrbuterol
1. 65652-44-0
2. Maxair
3. Pirbuterol Acetate [usan]
4. Spirolair
5. Pirbuterol Monoacetate
6. Cp-24,314-14
7. 1eh73xkr9n
8. 65652-44-0 (acetate)
9. 2-(hydroxymethyl)-6-(1-hydroxy-2-tert-butylamino-ethyl)-pyridin-3-ol
10. Cp 24314-14; Maxair;spirolair
11. Cp-24314-14
12. Pirbuterol Acetate (usan)
13. Acetic Acid;6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol
14. 6-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)pyridin-3-ol; Acetic Acid
15. Einecs 265-862-4
16. Unii-1eh73xkr9n
17. Maxair (tn)
18. Schembl3600
19. Alpha(sup 6)-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)
20. Chebi:8246
21. Chembl1200444
22. Dtxsid40984214
23. Pirbuterol Acetate [vandf]
24. Pirbuterol Acetate [mart.]
25. Pirbuterol Monoacetate [mi]
26. Pirbuterol Acetate [who-dd]
27. Alpha6-((tert-butylamino)methyl)-3-hydroxypyridine-2,6-dimethanol Monoacetate
28. Pirbuterol Acetate [orange Book]
29. 2,6-pyridinedimethanol, Alpha(sup 6)-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)
30. D00686
31. Pirbuterol Acetate 100 Microg/ml In Acetonitrile
32. Pirbuterol Acetate, Vetranal(tm), Analytical Standard
33. Q27252326
34. Pirbuterol Acetate, United States Pharmacopeia (usp) Reference Standard
35. Acetic Acid--6-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)pyridin-3-ol (1/1)
36. .alpha.6-((tert-butylamino)methyl)-3-hydroxy-2,6-pyridinedimethanol Monoacetate (salt)
37. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Acetate (1:1)
38. 2,6-pyridinedimethanol, .alpha.6-(((1,1-dimethylethyl)amino)methyl)-3-hydroxy-, Monoacetate (salt)
Molecular Weight | 300.35 g/mol |
---|---|
Molecular Formula | C14H24N2O5 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 5 |
Exact Mass | 300.16852187 g/mol |
Monoisotopic Mass | 300.16852187 g/mol |
Topological Polar Surface Area | 123 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 261 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Maxair |
PubMed Health | Pirbuterol (By breathing) |
Drug Classes | Bronchodilator |
Drug Label | The active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace... |
Active Ingredient | Pirbuterol acetate |
Dosage Form | Aerosol, metered |
Route | Inhalation |
Strength | eq 0.2mg base/inh |
Market Status | Prescription |
Company | Medicis |
2 of 2 | |
---|---|
Drug Name | Maxair |
PubMed Health | Pirbuterol (By breathing) |
Drug Classes | Bronchodilator |
Drug Label | The active component of MAXAIR AUTOHALER (pirbuterol acetate) is (R,S)6-{[(1,1-dimethylethyl)amino]methyl}-3-hydroxy-2,6-pyridinedimethanol monoacetate salt, a beta-2 adrenergic bronchodilator, having the following chemical structure:Pirbuterol ace... |
Active Ingredient | Pirbuterol acetate |
Dosage Form | Aerosol, metered |
Route | Inhalation |
Strength | eq 0.2mg base/inh |
Market Status | Prescription |
Company | Medicis |
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Cardiotonic Agents
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?